Aplindore
Based on 1 Customer Validation
Aplindore (DAB-452) is a potent agonist of the dopamine D2 receptor, with the pKi of 9.1. Aplindore plays an important role in Parkinson's disease research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98.44%
- CAS No.: 189681-70-7
- Formule: C18H18N2O3
- Masse moléculaire:310.35
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Voir tous les produits spécifiques à Isoform Dopamine Receptor
More
Activité biologique
Description
IC50 & Target
|
D2 Receptor 9.1 (pKi) |
Chemical Information
-
CAS No. 189681-70-7
-
Appearance Solid
-
Masse moléculaire 310.35
-
Formule C18H18N2O3
-
Color White to off-white
-
SMILES
O=C(C1)NC2=C1C(O[C@H]3CNCC4=CC=CC=C4)=C(OC3)C=C2
-
Synonyms
DAB-452
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocole
-
Double or multiplex chromogenic IHC
Double or multiplex chromogenic IHC detects two or more protein targets in the same FFPE tissue section by repeated antigen-antibody binding, enzyme-linked detection, chromogen deposition, image capture, and, for higher-plex workflows, removal or destaining before the next staining cycle. Chromogenic readouts are generated as colored precipitates at antigen sites, enabling evaluation of marker expression, cell phenotype, and spatial relationships in preserved tissue architecture. Classic examples include MICSSS, which performs iterative chromogenic IHC staining, scanning, and destaining on a single slide, and p16/Ki-67 dual staining, which uses chromogenic co-detection to identify cervical cells with combined cell-cycle deregulation and proliferation signals.
-
Human pluripotent stem cell midbrain dopaminergic neuron differentiation
Human pluripotent stem cells are directed toward midbrain dopaminergic neurons by first inducing a neural floor-plate-like progenitor state, then patterning cells with ventralizing SHH signaling and midbrain/WNT-FGF cues, and finally maturing progenitors into neurons expressing dopaminergic markers such as TH, NURR1/NR4A2, PITX3, DAT/SLC6A3, VMAT2/SLC18A2, GIRK2/KCNJ6, FOXA2, LMX1A, and EN1. The main readouts are loss of pluripotency, acquisition of FOXA2+/LMX1A+ midbrain floor-plate progenitors, emergence of βIII-tubulin+/MAP2+ neurons, and production of TH+ dopaminergic neurons with molecular, dopamine-release, and electrophysiological features of midbrain dopaminergic identity.
Pureté et documentation
-
Fiche technique (266 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instruction de manipulation (2659 KB)
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)